The present application relates to novel substituted indazoles, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of endometriosis and endometriosis-associated pain and other endometriosis-associated symptoms such as dysmenorrhoea, dyspareunia, dysuria and dyschezia, of lymphoma, rheumatoid arthritis, spondyloarthritis (especially psoriatic spondyloarthritis and Bekhterev's disease), lupus erythematosus, multiple sclerosis, macular degeneration, COPD, gout, fatty liver disorders, insulin resistance, neoplastic disorders and psoriasis.

Download PDF
Document Preview
Document History
  • Publication: Oct 8, 2019
  • Application: Feb 28, 2017
    US US 201716081209 A
  • Priority: Feb 28, 2017
    EP EP 2017054577 W
  • Priority: Mar 3, 2016
    EP EP 16158542 A

Download Citation

Sign in to the Lens